newsfilter
← Latest News
PR Newswire·

Mirati Therapeutics Reports Third Quarter 2023 Financial Results and Recent Corporate Updates

Mirati Therapeutics, Inc.® (NASDAQ: MRTX), a commercial stage biotechnology company, today announced financial results for the third quarter 2023...